Repositorio Dspace

Impact of the COVID-19 Pandemic on the Outcomes of a Multifaceted Program on Antibiotic Prescribing in Primary Care Among Children Under Three Years of Age

Mostrar el registro sencillo del ítem

dc.contributor.author Martín-Ayala, Gema
dc.contributor.author Alfayate-Miguélez, Santiago
dc.contributor.author Jiménez-Guillén, Casimiro
dc.contributor.author AlcarazQuiñonero, Manuel
dc.contributor.author Iofrio-de-Arce, Antonio
dc.contributor.author Arnau-Sánchez, José
dc.date.accessioned 2026-04-20T09:45:49Z
dc.date.available 2026-04-20T09:45:49Z
dc.date.issued 2026-01-19
dc.identifier.citation Martín-Ayala G, Alfayate-Miguélez S, Jiménez-Guillén C, Alcaraz-Quiñonero M, Iofrío-De Arce A, Arnau-Sánchez J. Impact of the COVID-19 Pandemic on the Outcomes of a Multifaceted Program on Antibiotic Prescribing in Primary Care Among Children Under Three Years of Age. Antibiotics. 19 de enero de 2026;15(1):101. doi:10.3390/antibiotics15010101
dc.identifier.issn 2079-6382
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/25980
dc.description.abstract Background/objective: Inappropriate antibiotic use in paediatric populations is a leading driver of antimicrobial resistance. In the Murcia Region, Spain, the Purapi program promotes the rational use of antibiotics among children under 3 years of age. This study aimed to analyse antibiotic use in this age group during the pandemic period (2020-2023) and to assess the impact of the COVID-19 pandemic on the effectiveness of a multifaceted program promoting appropriate antibiotic use. Methods: A retrospective, multicentre, population-based study was conducted in primary care using data from 2019 to 2024. Systemic antibiotic use (ATC J01 group) among children under three years was measured as defined daily doses per 1000 inhabitants per day (DHD). Differences across years and healthcare areas were assessed using analysis of variance (ANOVA) with Bonferroni correction. Results: Antibiotic consumption decreased by 49% in 2020 compared to 2019, coinciding with the implementation of national COVID-19 containment measures. From 2021 onward, a gradual increase was observed; however, by 2024, levels remained 9% below pre-pandemic values. Penicillins account for 75% of prescriptions, mainly amoxicillin and amoxicillin-clavulanic acid. While variability across healthcare areas decreased during the pandemic, variability among primary care centres increased. Conclusions: The pandemic resulted in a temporary reduction in antibiotic use, followed by a partial rebound. Ongoing educational and stewardship interventions within the Purapi framework were instrumental in maintaining rational prescribing and may have contributed to maintaining reduced antibiotic consumption among children under three years of age during and after the pandemic. Strengthening and harmonising these initiatives is essential to ensure consistent paediatric antibiotic stewardship in primary care.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Impact of the COVID-19 Pandemic on the Outcomes of a Multifaceted Program on Antibiotic Prescribing in Primary Care Among Children Under Three Years of Age
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 41594137
dc.relation.publisherversion https://www.mdpi.com/2079-6382/15/1/101
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3390/antibiotics15010101
dc.journal.title Antibiotics-Basel


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta